ALMKT:EPA
Mauna Kea Technologies SA
€ 0.091
arrow_downward
-1.62%(-0.0015) Siku 1
6 Nov, 17:35:04 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.08
Juu
€ 0.09
Chini
€ 0.08
Mtaji wa soko
17.79M
Wastani wa kiasi cha mauzo
elfu 549.48
Kiasi cha mauzo ya hisa
elfu 385.57
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.78
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.08
Juu
€ 0.09
Chini
€ 0.08
Mtaji wa soko
17.79M
Wastani wa kiasi cha mauzo
elfu 549.48
Kiasi cha mauzo ya hisa
elfu 385.57
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.78
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
dakika 29 zilizopita
Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More
The Motley Fool
·
saa 1 iliyopita
No Matter What Happens to the S&P 500 in November, These 3 Dividend Stocks Belong in Your Portfolio
Yahoo Finance
·
dakika 26 zilizopita
Microsoft (MSFT) Makes the 10 Best Dow Stocks for 2027 List as Azure Growth Speeds Up
Bloomberg.com
·
siku 1 iliyopita
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com